JP2010511389A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511389A5
JP2010511389A5 JP2009539524A JP2009539524A JP2010511389A5 JP 2010511389 A5 JP2010511389 A5 JP 2010511389A5 JP 2009539524 A JP2009539524 A JP 2009539524A JP 2009539524 A JP2009539524 A JP 2009539524A JP 2010511389 A5 JP2010511389 A5 JP 2010511389A5
Authority
JP
Japan
Prior art keywords
circulating
fibrosis
subject
disease
fibrotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009539524A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010511389A (ja
JP5296701B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086167 external-priority patent/WO2008067559A2/en
Publication of JP2010511389A publication Critical patent/JP2010511389A/ja
Publication of JP2010511389A5 publication Critical patent/JP2010511389A5/ja
Application granted granted Critical
Publication of JP5296701B2 publication Critical patent/JP5296701B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009539524A 2006-11-30 2007-11-30 線維性疾患および線維増殖性疾患を処置および診断するための方法 Expired - Fee Related JP5296701B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87201906P 2006-11-30 2006-11-30
US60/872,019 2006-11-30
PCT/US2007/086167 WO2008067559A2 (en) 2006-11-30 2007-11-30 Methods for treating and diagnosing fibrotic and fibroproliferative diseases

Publications (3)

Publication Number Publication Date
JP2010511389A JP2010511389A (ja) 2010-04-15
JP2010511389A5 true JP2010511389A5 (enExample) 2011-01-20
JP5296701B2 JP5296701B2 (ja) 2013-09-25

Family

ID=39468768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009539524A Expired - Fee Related JP5296701B2 (ja) 2006-11-30 2007-11-30 線維性疾患および線維増殖性疾患を処置および診断するための方法

Country Status (5)

Country Link
US (2) US8114608B2 (enExample)
EP (1) EP2100140B1 (enExample)
JP (1) JP5296701B2 (enExample)
AU (1) AU2007325029B2 (enExample)
WO (1) WO2008067559A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5380287B2 (ja) 2006-07-18 2014-01-08 ノクソン・ファルマ・アクチエンゲゼルシャフト Sdf−1結合核酸
PT2190991T (pt) * 2007-08-06 2019-12-16 Noxxon Pharma Ag Ácidos nucleicos que se ligam a sdf 1 e a sua utilização
CA2745027A1 (en) * 2008-10-22 2010-04-29 Allocure, Inc. Methods of using sdf-1 (cxcl12) as a diagnostic and mesenchymal stem cell (multipotent stromal cell)-specific therapeutic biomarker for the treatment of kidney injury and other major organs
JP2012127879A (ja) * 2010-12-16 2012-07-05 Kanazawa Univ 腎症の進行度の判定方法並びに線維化抑制剤。
CN103376228B (zh) * 2012-04-27 2016-02-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种检测或辅助检测放射性肺纤维化的试剂盒
US9952202B2 (en) * 2013-03-14 2018-04-24 Galapagos Nv Methods of identifying compounds for the treatment of fibrosis by using S1PR5
JP6601707B2 (ja) * 2015-02-15 2019-11-06 国立大学法人金沢大学 線維化判定方法
JP7126668B2 (ja) * 2017-08-09 2022-08-29 国立大学法人金沢大学 膠原病判定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759036B1 (en) * 1997-03-28 2004-07-06 The Picower Institute For Medical Research Fibrocyte-base vaccine formulations
US8293479B2 (en) * 2002-05-02 2012-10-23 Los Angeles Biomedical Research Institute At Harbor Ucla Medical Center Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies
JP4922560B2 (ja) * 2002-12-23 2012-04-25 ウイリアム、マーシュ、ライス、ユーニヴァーサティ 線維細胞への分化の検出方法、線維症を抑制する組成物および方法

Similar Documents

Publication Publication Date Title
JP2021523103A (ja) Il−33を含有するマトリックス結合型小胞(mbvs)およびそれらの使用
He et al. Ultrastructure of mitochondria and the endoplasmic reticulum in renal tubules of Dahl salt-sensitive rats
Kazantsev et al. Hybrid revascularization of the heart and brain: which carotid endarterectomy is preferable?
JP2017530954A5 (enExample)
Zhu et al. Lund exhaust on hemodynamic parameters and inflammatory mediators in patients undergoing cardiac valve replacement under cardiopulmonary bypass
CN120898134A (zh) Mpo抑制剂治疗方法
Figuinha et al. Heyde's syndrome: case report and literature review
JP2018162308A5 (enExample)
Lu et al. Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function
Tanaka et al. Aortic valve replacement for aortic regurgitation with rare left ventricular non-compaction
JP2020533373A5 (enExample)
Refaat et al. Long-Term Impact of Device Closure of Atrial Septal Defect on Cardiac Mechancial and Electric Remodeling
Gordon et al. Scar Size and Other Parameters for Tracking Left Ventricular Dysfunction after Induction of Myocardial Infarcts in Sheep (Ovis aries)
Mahung et al. 41 Peripheral Mononuclear Cell Expression of IL-10, IL-12, ARG1, & NOS2 Correlates with Outcomes After Burn
Martinelli et al. Hypereosinophilic syndrome and molecularly targeted therapy
杨萍 et al. The relationship between serum miR-129 expression and cardiac function in patients with chronic systolic heart failure
Bankir et al. MO422: Strong Positive Association Between GFR and the Urine-To-Plasma Urea Concentration Ratio in Patients With Sickle Cell Disease. Possible Functional Meaning
Tayyareci et al. Intracoronary Autologous Bone Marrow− Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach
Hijazi et al. OP-134: PERIOPERATIVE ADMINISTRATION OF LEVOSIMENDAN TO PATIENTS WITH PREOPERATIVE LEFT VENTRICULAR DYSFUNCTION WHO ARE EXPECTED NOT TO BE WEANED FROM CARDIOPULMONARY BYPASS EASILY
Shevchenko et al. Cardiac transplant rejection and non-invasive comon carotid artery wall functional indices
Tserendavaa et al. TCTAP A-054 The Study Endothelial Nitric Oxide Synthase Enzyme of EPC Colonies in the Coronary Atherosclerosis
Debicka-Dabrowska et al. [PP. 36.04]: USEFULNESS OF SLOW BREATHING TRAINING IN CHRONIC HEART FAILURE. STUDY DESIGN AND INTERMEDIATE RESULTS
Omoto et al. Aortic valve replacement in a patient with alpha-thalassemia
Wein et al. The cardiomyopathies
Qin et al. Targeting Ischaemia-reperfusion (IR) Injury in the Intact Heart with Annexin-A1 (ANX-A1) Mimetics